Found 93 hits of affinity data for UniProtKB/TrEMBL: Q7KQM4Target (Institution) | Ligand | Target Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | pH | Temp °C |
Plasmepsin I
Plasmodium falciparum | Statine-like inhibitor 16
 ((3S,4S)-5-[(4-bromophenyl)methoxy]-N-[(1S)-1-{[(1S...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CHEBI CSLS MMDB PC cid PC sid PDB
| PubMed
| 0.5000 | -52.55 | n/a | n/a | n/a | 4.5 | 22 |
Linkoping University
|
J Med Chem. 47: 3353-66 (2004)
|
Plasmepsin I
Plasmodium falciparum | C2-symmetric compound 15
 ((2R,3R,4R,5R)-2,5-bis({[(2E)-3-(2H-1,3-benzodioxol...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| 0.5000 | -52.55 | n/a | n/a | n/a | 4.5 | 22 |
Uppsala University
|
J Med Chem. 47: 110-22 (2004)
|
Plasmepsin I
Plasmodium falciparum | C2-symmetric compound 13
 ((2R,3R,4R,5R)-2,5-bis({[(2E)-3-(4-acetylphenyl)pro...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| 0.8000 | -51.40 | n/a | n/a | n/a | 4.5 | 22 |
Uppsala University
|
J Med Chem. 47: 110-22 (2004)
|
Plasmepsin I
Plasmodium falciparum | C2-symmetric compound 16
 ((2R,3R,4R,5R)-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hyd...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| 1.300 | -50.20 | n/a | n/a | n/a | 4.5 | 22 |
Uppsala University
|
J Med Chem. 47: 110-22 (2004)
|
Plasmepsin I
Plasmodium falciparum | C2-symmetric compound 10
 ((2R,3R,4R,5R)-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hyd...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| 1.400 | -50.02 | n/a | n/a | n/a | 4.5 | 22 |
Uppsala University
|
J Med Chem. 47: 110-22 (2004)
|
Plasmepsin I
Plasmodium falciparum | hydroxylethylamine scaffold 69
 ((2S)-N-[(2S,3S)-4-{[(1S)-1-carbamoyl-2-(4-phenylph...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| 2.000 | -49.15 | n/a | n/a | n/a | 4.5 | 22 |
Uppsala University
|
J Comb Chem. 5: 456-64 (2003)
|
Plasmepsin I
Plasmodium falciparum | C2-symmetric compound 11
 ((2R,3R,4R,5R)-2,5-bis({[(2E)-3-(4-fluorophenyl)pro...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| 2.500 | -48.60 | n/a | n/a | n/a | 4.5 | 22 |
Uppsala University
|
J Med Chem. 47: 110-22 (2004)
|
Plasmepsin I
Plasmodium falciparum | Hydroxylethylamine deriv. 23
 ((2S)-N-[(2S,3S)-4-{[(1S)-1-carbamoyl-2-(4-phenylph...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| 2.600 | -48.50 | n/a | n/a | n/a | 4.5 | 22 |
Uppsala University
|
J Med Chem. 47: 110-22 (2004)
|
Plasmepsin I
Plasmodium falciparum | Statine-like inhibitor 27
 ((3S,4S)-5-[(4-bromophenyl)methoxy]-N-[(1S)-1-{[(1S...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CHEBI CSLS PC cid PC sid
| PubMed
| 3.400 | -47.84 | n/a | n/a | n/a | 4.5 | 22 |
Linkoping University
|
J Med Chem. 47: 3353-66 (2004)
|
Plasmepsin I
Plasmodium falciparum | C2-symmetric compound 19
 ((2R,3R,4R,5R)-N1,N6-Bis[(1S,2R)-2-hydroxy-1-indany...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| 3.700 | -47.64 | n/a | n/a | n/a | 4.5 | 22 |
Uppsala University
|
J Med Chem. 47: 110-22 (2004)
|
Plasmepsin I
Plasmodium falciparum | Statine-like inhibitor 18
 ((3S,4S)-5-[(4-bromophenyl)methoxy]-N-(cyclohexylme...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| 3.900 | -47.51 | n/a | n/a | n/a | 4.5 | 22 |
Linkoping University
|
J Med Chem. 47: 3353-66 (2004)
|
Plasmepsin I
Plasmodium falciparum | hydroxylethylamine scaffold 113
 ((2S)-N-[(2S,3S)-4-{[(1S)-2-[4-(1-benzofuran-2-yl)p...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| 4.100 | -47.39 | n/a | n/a | n/a | 4.5 | 22 |
Uppsala University
|
J Comb Chem. 5: 456-64 (2003)
|
Plasmepsin I
Plasmodium falciparum | Statine-like inhibitor 22
 ((3S,4S)-5-[(4-bromophenyl)methoxy]-N-cyclohexyl-3-...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| 4.100 | -47.39 | n/a | n/a | n/a | 4.5 | 22 |
Linkoping University
|
J Med Chem. 47: 3353-66 (2004)
|
Plasmepsin I
Plasmodium falciparum | C2-symmetric compound 18
 ((2R,3R,4R,5R)-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hyd...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| 4.400 | -47.21 | n/a | n/a | n/a | 4.5 | 22 |
Uppsala University
|
J Med Chem. 47: 110-22 (2004)
|
Plasmepsin I
Plasmodium falciparum | C2-symmetric compound 18
 ((2R,3R,4R,5R)-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hyd...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| 4.400 | -47.21 | n/a | n/a | n/a | 4.5 | 22 |
Uppsala University
|
J Med Chem. 47: 110-22 (2004)
|
Plasmepsin I
Plasmodium falciparum | hydroxylethylamine scaffold 53
 ((2S)-N-[(2S,3S)-4-{[(1S)-2-(4-bromophenyl)-1-carba...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| 4.700 | -47.05 | n/a | n/a | n/a | 4.5 | 22 |
Uppsala University
|
J Comb Chem. 5: 456-64 (2003)
|
Plasmepsin I
Plasmodium falciparum | hydroxylethylamine scaffold 103
 ((2S)-N-[(2S,3S)-4-{[(1S)-2-[4-(2H-1,3-benzodioxol-...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| 4.800 | -47.00 | n/a | n/a | n/a | 4.5 | 22 |
Uppsala University
|
J Comb Chem. 5: 456-64 (2003)
|
Plasmepsin I
Plasmodium falciparum | Statine-like inhibitor 15
 ((3S,4S)-5-(benzyloxy)-N-[(1S)-1-{[(1S)-1-carbamoyl...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| 5.400 | -46.71 | n/a | n/a | n/a | 4.5 | 22 |
Linkoping University
|
J Med Chem. 47: 3353-66 (2004)
|
Plasmepsin I
Plasmodium falciparum | Statine-like inhibitor 17
 ((3S,4S)-5-[(4-bromophenyl)methoxy]-3-hydroxy-4-[(2...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| 5.400 | -46.71 | n/a | n/a | n/a | 4.5 | 22 |
Linkoping University
|
J Med Chem. 47: 3353-66 (2004)
|
Plasmepsin I
Plasmodium falciparum | C2-symmetric compound 12
 ((2R,3R,4R,5R)-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hyd...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| 5.800 | -46.53 | n/a | n/a | n/a | 4.5 | 22 |
Uppsala University
|
J Med Chem. 47: 110-22 (2004)
|
Plasmepsin I
Plasmodium falciparum | Statine-like inhibitor 25
 ((3S,4S)-5-[(4-bromophenyl)methoxy]-N-[(1S)-1-{[(1S...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| 6.400 | -46.29 | n/a | n/a | n/a | 4.5 | 22 |
Linkoping University
|
J Med Chem. 47: 3353-66 (2004)
|
Plasmepsin I
Plasmodium falciparum | Statine-like inhibitor 20
 ((3S,4S)-5-[(4-bromophenyl)methoxy]-3-hydroxy-N-[2-...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| 6.700 | -46.18 | n/a | n/a | n/a | 4.5 | 22 |
Linkoping University
|
J Med Chem. 47: 3353-66 (2004)
|
Plasmepsin I
Plasmodium falciparum | C2-symmetric compound 20
 ((2R,3R,4R,5R)-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hyd...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| 7.200 | -46.00 | n/a | n/a | n/a | 4.5 | 22 |
Uppsala University
|
J Med Chem. 47: 110-22 (2004)
|
Plasmepsin I
Plasmodium falciparum | Statine-like inhibitor 24
 ((3S,4S)-5-[(4-bromophenyl)methoxy]-N-butyl-3-hydro...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CHEBI CSLS PC cid PC sid
| PubMed
| 8.100 | -45.71 | n/a | n/a | n/a | 4.5 | 22 |
Linkoping University
|
J Med Chem. 47: 3353-66 (2004)
|
Plasmepsin I
Plasmodium falciparum | C2-symmetric compound 14
 ((2R,3R,4R,5R)-2,5-bis({[(2E)-3-(2,4-dimethoxypyrim...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| 8.400 | -45.63 | n/a | n/a | n/a | 4.5 | 22 |
Uppsala University
|
J Med Chem. 47: 110-22 (2004)
|
Plasmepsin I
Plasmodium falciparum | Statine-like inhibitor 21
 ((3S,4S)-5-[(4-bromophenyl)methoxy]-3-hydroxy-4-[(2...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| 8.900 | -45.48 | n/a | n/a | n/a | 4.5 | 22 |
Linkoping University
|
J Med Chem. 47: 3353-66 (2004)
|
Plasmepsin I
Plasmodium falciparum | hydroxylethylamine scaffold 61
 ((2S)-N-[(2S,3S)-4-{[(1S)-1-carbamoyl-2-(4-phenylph...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| 12.00 | -44.75 | n/a | n/a | n/a | 4.5 | 22 |
Uppsala University
|
J Comb Chem. 5: 456-64 (2003)
|
Plasmepsin I
Plasmodium falciparum | hydroxylethylamine scaffold 101
 ((2S)-N-[(2S,3S)-4-{[(1S)-2-[4-(2H-1,3-benzodioxol-...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| 12.00 | -44.75 | n/a | n/a | n/a | 4.5 | 22 |
Uppsala University
|
J Comb Chem. 5: 456-64 (2003)
|
Plasmepsin I
Plasmodium falciparum | hydroxylethylamine scaffold 93
 ((2S)-N-[(2S,3S)-4-{[(1S)-2-[4-(1-benzofuran-2-yl)p...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| 13.00 | -44.55 | n/a | n/a | n/a | 4.5 | 22 |
Uppsala University
|
J Comb Chem. 5: 456-64 (2003)
|
Plasmepsin I
Plasmodium falciparum | Statine-like inhibitor A
 ((3S,4S)-N-[(1S)-1-{[(1S)-1-carbamoyl-3-methylbutyl...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CHEBI CSLS PC cid PC sid
| PubMed
| 16.00 | -44.04 | n/a | n/a | n/a | 4.5 | 22 |
Linkoping University
|
J Med Chem. 47: 3353-66 (2004)
|
Plasmepsin I
Plasmodium falciparum | hydroxylethylamine scaffold 64
 ((2S)-N-[(2S,3S)-4-{[(1S)-1-carbamoyl-2-(4-phenylph...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| 18.00 | -43.76 | n/a | n/a | n/a | 4.5 | 22 |
Uppsala University
|
J Comb Chem. 5: 456-64 (2003)
|
Plasmepsin I
Plasmodium falciparum | hydroxylethylamine scaffold 118
 ((2S)-N-[(2S,3S)-4-{[(1S)-2-[4-(1-benzofuran-2-yl)p...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| 20.00 | -43.50 | n/a | n/a | n/a | 4.5 | 22 |
Uppsala University
|
J Comb Chem. 5: 456-64 (2003)
|
Plasmepsin I
Plasmodium falciparum | hydroxylethylamine scaffold 92
 ((2S)-N-[(2S,3S)-4-{[(1S)-2-[4-(2H-1,3-benzodioxol-...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| 23.00 | -43.15 | n/a | n/a | n/a | 4.5 | 22 |
Uppsala University
|
J Comb Chem. 5: 456-64 (2003)
|
Plasmepsin I
Plasmodium falciparum | C2-symmetric compound 17
 ((2R,3R,4R,5R)-2,5-bis({[(2E)-3-(3,5-dimethyl-1,2-o...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| 23.00 | -43.15 | n/a | n/a | n/a | 4.5 | 22 |
Uppsala University
|
J Med Chem. 47: 110-22 (2004)
|
Plasmepsin I
Plasmodium falciparum | Statine-like inhibitor 30
 ((3S,4S)-5-(4-Bromobenzyloxy)-3-hydroxy-4-(2-thioph...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| 24.00 | -43.05 | n/a | n/a | n/a | 4.5 | 22 |
Linkoping University
|
J Med Chem. 47: 3353-66 (2004)
|
Plasmepsin I
Plasmodium falciparum | hydroxylethylamine scaffold 68
 ((2S)-N-[(2S,3S)-4-{[(1S)-1-carbamoyl-2-(4-phenylph...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| 24.00 | -43.05 | n/a | n/a | n/a | 4.5 | 22 |
Uppsala University
|
J Comb Chem. 5: 456-64 (2003)
|
Plasmepsin I
Plasmodium falciparum | C2-symmetric compound 8
 ((2R,3R,4R,5R)-2,5-bis(benzyloxy)-3,4-dihydroxy-N,N...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| B.MOAD CSLS MMDB PC cid PC sid PDB
| PubMed
| 25.00 | -42.95 | n/a | n/a | n/a | 4.5 | 22 |
Uppsala University
|
J Med Chem. 47: 110-22 (2004)
|
Plasmepsin I
Plasmodium falciparum | Statine-like inhibitor 14
 ((3S,4S)-N-[(1S)-1-{[(1S)-1-carbamoyl-3-methylbutyl...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| 27.00 | -42.76 | n/a | n/a | n/a | 4.5 | 22 |
Linkoping University
|
J Med Chem. 47: 3353-66 (2004)
|
Plasmepsin I
Plasmodium falciparum | C2-symmetric compound 9
 ((2R,3R,4R,5R)-2,5-bis({[(2E)-3-bromoprop-2-en-1-yl...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CHEBI CSLS PC cid PC sid
| PubMed
| 27.00 | -42.76 | n/a | n/a | n/a | 4.5 | 22 |
Uppsala University
|
J Med Chem. 47: 110-22 (2004)
|
Plasmepsin I
Plasmodium falciparum | hydroxylethylamine scaffold 59
 ((2S)-N-[(2S,3S)-4-{[(1S)-2-(4-bromophenyl)-1-carba...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| 27.00 | -42.76 | n/a | n/a | n/a | 4.5 | 22 |
Uppsala University
|
J Comb Chem. 5: 456-64 (2003)
|
Plasmepsin I
Plasmodium falciparum | Statine-like inhibitor 31
 ((3S,4S)-4-(2H-1,3-benzodioxol-5-ylformamido)-5-[(4...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| 29.00 | -42.58 | n/a | n/a | n/a | 4.5 | 22 |
Linkoping University
|
J Med Chem. 47: 3353-66 (2004)
|
Plasmepsin I
Plasmodium falciparum | hydroxylethylamine scaffold 51
 ((2S)-N-[(2S,3S)-4-{[(1S)-2-(4-bromophenyl)-1-carba...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| 29.00 | -42.58 | n/a | n/a | n/a | 4.5 | 22 |
Uppsala University
|
J Comb Chem. 5: 456-64 (2003)
|
Plasmepsin I
Plasmodium falciparum | Statine-like inhibitor 26
 ((3S,4S)-5-[(4-bromophenyl)methoxy]-N-[(1S)-1-{[(1S...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| 32.00 | -42.34 | n/a | n/a | n/a | 4.5 | 22 |
Linkoping University
|
J Med Chem. 47: 3353-66 (2004)
|
Plasmepsin I
Plasmodium falciparum | C2-symmetric compound 22
 ((2R,3R,4R,5R)-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hyd...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| 32.00 | -42.34 | n/a | n/a | n/a | 4.5 | 22 |
Uppsala University
|
J Med Chem. 47: 110-22 (2004)
|
Plasmepsin I
Plasmodium falciparum | hydroxylethylamine scaffold 65
 ((2S)-N-[(2S,3S)-4-{[(1S)-1-carbamoyl-2-(4-phenylph...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| 33.00 | -42.27 | n/a | n/a | n/a | 4.5 | 22 |
Uppsala University
|
J Comb Chem. 5: 456-64 (2003)
|
Plasmepsin I
Plasmodium falciparum | hydroxylethylamine scaffold 111
 ((2S)-N-[(2S,3S)-4-{[(1S)-2-[4-(1-benzofuran-2-yl)p...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| 35.00 | -42.12 | n/a | n/a | n/a | 4.5 | 22 |
Uppsala University
|
J Comb Chem. 5: 456-64 (2003)
|
Plasmepsin I
Plasmodium falciparum | C2-symmetric compound 21
 ((2R,3R,4R,5R)-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hyd...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| 37.00 | -41.99 | n/a | n/a | n/a | 4.5 | 22 |
Uppsala University
|
J Med Chem. 47: 110-22 (2004)
|
Plasmepsin I
Plasmodium falciparum | Statine-like inhibitor 29
 ((3S,4S)-5-(4-Bromobenzyloxy)-4-(3,3-diphenylpropio...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| 40.00 | -41.80 | n/a | n/a | n/a | 4.5 | 22 |
Linkoping University
|
J Med Chem. 47: 3353-66 (2004)
|
Plasmepsin I
Plasmodium falciparum | hydroxylethylamine scaffold 96
 ((2E)-3-(3-{4-[(2S)-2-carbamoyl-2-{[(2S,3S)-2-hydro...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| 42.00 | -41.68 | n/a | n/a | n/a | 4.5 | 22 |
Uppsala University
|
J Comb Chem. 5: 456-64 (2003)
|
Plasmepsin I
Plasmodium falciparum | hydroxylethylamine scaffold 55
 ((2S)-N-[(2S,3S)-4-{[(1S)-2-(4-bromophenyl)-1-carba...) | GoogleScholar KEGG UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| 46.00 | -41.45 | n/a | n/a | n/a | 4.5 | 22 |
Uppsala University
|
J Comb Chem. 5: 456-64 (2003)
|